Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury

Experimental Neurology

Volumn 221, Issue 2, 2010, Pages 285-295

  Mann, Cody M ^a   Lee, Jae H T ^a   Hillyer, Jessica ^a   Stammers, Anthea M T ^a   Tetzlaff, Wolfram ^a   Kwon, Brian K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Atorvastatin; Neuroprotection; Simvastatin; Spinal cord injury

Indexed keywords

ATORVASTATIN; ENSURE; SIMVASTATIN; SODIUM CHLORIDE;

ACUTE THORACIC SPINAL CORD CONTUSION INJURY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG RESPONSE; HISTOPATHOLOGY; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPINAL CORD INJURY; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BENZENESULFONATES; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; ECTODYSPLASINS; EXPLORATORY BEHAVIOR; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; PAIN MEASUREMENT; PAIN THRESHOLD; PSYCHOMOTOR PERFORMANCE; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SACROCOCCYGEAL REGION; SIMVASTATIN; SPINAL CORD INJURIES;

EID: 73949139517     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.11.006     Document Type: Article

References (40)

1. Balduini W., De V A., Mazzoni E., and Cimino M. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury. Stroke 32 (2001) 2185-2191
2. Balduini W., Mazzoni E., Carloni S., De Simoni M.G., Perego C., Sironi L., and Cimino M. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 34 (2003) 2007-2012
3. Bartesaghi S., Marinovich M., Corsini E., Galli C.L., and Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26 5 (2005) 923-928
4. Basso D.M. Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J. Neurotrauma 21 (2004) 395-404
5. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12 (1995) 1-21
6. Cimino M., Gelosa P., Gianella A., Nobili E., Tremoli E., and Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 13 3 (2007) 208-213 (Review)
7. Cimino M., Balduini W., Carloni S., Gelosa P., Guerrini U., Tremoli E., and Sironi L. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology 26 5 (2005) 929-933
8. Dery M.A., Rousseau G., Benderdour M., and Beaumont E. Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery. Neurosci. Lett. 453 (2009) 73-76
9. Domercq M., and Matute C. Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 25 (2004) 609-612
10. Endres M., Laufs U., Huang Z., Nakamura T., Huang P., Moskowitz M.A., and Liao J.K. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8880-8885
11. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., Di Giulio A.M., Vardar E., Cerami A., and Brines M. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9450-9455
12. Hamers F.P., Koopmans G.C., and Joosten E.A. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma 23 (2006) 537-548
13. Holmberg E., Nordstrom T., Gross M., Kluge B., Zhang S.X., and Doolen S. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury. J. Neurotrauma 23 (2006) 1366-1378
14. Holmberg E., Zhang S.X., Sarmiere P.D., Kluge B.R., White J.T., and Doolen S. Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury. Exp. Neurol. (2008)
15. Hurlbert R.J., and Hamilton M.G. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can. J. Neurol. Sci. 35 (2008) 41-45
16. Igel M., Sudhop T., and von B.K. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). Eur. J. Clin. Pharmacol. 57 (2001) 357-364
17. Igel M., Sudhop T., and von B.K. Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin. J. Clin. Pharmacol. 42 (2002) 835-845
18. Kaptanoglu E., Solaroglu I., Okutan O., Surucu H.S., Akbiyik F., and Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg. Rev. 27 (2004) 113-120
19. Kugi M., Matsunaga A., Ono J., Arakawa K., and Sasaki J. Antioxidative effects of fluvastatin on superoxide anion activated by angiotensin II in human aortic smooth muscle cells. Cardiovasc. Drugs Ther. 16 (2002) 203-207
20. Kwon B.K., Hillyer J., and Tetzlaff W. Translational research in spinal cord injury: a survey of opinion from the SCI community. J. Neurotrauma. (2009) (Electronic publication ahead of print)
21. Liao J.K., and Laufs U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 89-118
22. Lu D., Qu C., Goussev A., Jiang H., Lu C., Schallert T., Mahmood A., Chen J., Li Y., and Chopp M. Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J. Neurotrauma 24 (2007) 1132-1146
23. McGirt M.J., Lynch J.R., Parra A., Sheng H., Pearlstein R.D., Laskowitz D.T., Pelligrino D.A., and Warner D.S. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 (2002) 2950-2956
24. Pannu R., Barbosa E., Singh A.K., and Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J. Neurosci. Res. 79 (2005) 340-350
25. Pannu R., Christie D.K., Barbosa E., Singh I., and Singh A.K. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. J. Neurochem. 101 (2007) 182-200
26. Pinzon A., Marcillo A., Pabon D., Bramlett H.M., Bunge M.B., and Dietrich W.D. A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury. Exp. Neurol. 213 (2008) 129-136
27. Pinzon A., Marcillo A., Quintana A., Stamler S., Bunge M.B., Bramlett H.M., and Dietrich W.D. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res. 1243 (2008) 146-151
28. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
29. Rabchevsky A.G., Fugaccia I., Sullivan P.G., and Scheff S.W. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18 5 (2001) 513-522
30. Romano M., Diomede L., Sironi M., Massimiliano L., Sottocorno M., Polentarutti N., Guglielmotti A., Albani D., Bruno A., Fruscella P., Salmona M., Vecchi A., Pinza M., and Mantovani A. Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab. Invest. 80 (2000) 1095-1100
31. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam. Clin. Pharmacol. 19 (2005) 117-125
32. Schwartz G., and Fehlings M.G. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J. Neurosurg. 94 (2001) 245-256
33. Sironi L., Cimino M., Guerrini U., Calvio A.M., Lodetti B., Asdente M., Balduini W., Paoletti R., and Tremoli E. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 322-327
34. Steward O., Sharp K., Yee K.M., and Hofstadter M. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp. Neurol. 209 (2008) 446-468
35. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., and Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24 (2004) 2182-2190
36. Stuve O., Youssef S., Steinman L., and Zamvil S.S. Statins as potential therapeutic agents in neuroinflammatory disorders. Curr. Opin. Neurol. 16 (2003) 393-401
37. Wang H., Lynch J.R., Song P., Yang H.J., Yates R.B., Mace B., Warner D.S., Guyton J.R., and Laskowitz D.T. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp. Neurol. 206 (2007) 59-69
38. Wells J.E., Hurlbert R.J., Fehlings M.G., and Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126 (2003) 1628-1637
39. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., and Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
40. Zacco A., Togo J., Spence K., Ellis A., Lloyd D., Furlong S., and Piser T. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 23 (2003) 11104-11111